APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prostaglandin E2 Receptor EP4 Subtype

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prostaglandin E2 Receptor EP4 Subtype Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025185 pages

Choose your research edition.

Industry ResearchProstaglandin E2 Receptor EP4 Subtype Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostaglandin E2 Receptor EP4 Subtype Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Prostaglandin E2 Receptor EP4 Subtype Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostaglandin E2 Receptor EP4 Subtype Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostaglandin E2 Receptor EP4 Subtype Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Prostaglandin E2 Receptor EP4 Subtype market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Prostaglandin E2 Receptor EP4 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostaglandin E2 Receptor EP4 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostaglandin E2 Receptor EP4 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prostaglandin E2 Receptor EP4 Subtype is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prostaglandin E2 Receptor EP4 Subtype include Eisai Co Ltd, Eli Lilly and Co, Rottapharm Biotech Srl, RaQualia Pharma Inc, Ono Pharmaceutical Co Ltd and Kaken Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Prostaglandin E2 Receptor EP4 Subtype market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostaglandin E2 Receptor EP4 Subtype and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostaglandin E2 Receptor EP4 Subtype revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Prostaglandin E2 Receptor EP4 Subtype market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostaglandin E2 Receptor EP4 Subtype Segment by Company

Eisai Co Ltd

Eli Lilly and Co

Rottapharm Biotech Srl

RaQualia Pharma Inc

Ono Pharmaceutical Co Ltd

Kaken Pharmaceutical Co Ltd

Prostaglandin E2 Receptor EP4 Subtype Segment by Type

ONO-4232

KAG-308

ER-886046

Grapiprant

E-7046

Others

Prostaglandin E2 Receptor EP4 Subtype Segment by Application

Breast Cancer

Chronic Pain

Acute Pain

Allergies

Lung Cancer

Others

Prostaglandin E2 Receptor EP4 Subtype Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin E2 Receptor EP4 Subtype market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin E2 Receptor EP4 Subtype and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin E2 Receptor EP4 Subtype.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Prostaglandin E2 Receptor EP4 Subtype in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostaglandin E2 Receptor EP4 Subtype industry.

Chapter 3: Detailed analysis of Prostaglandin E2 Receptor EP4 Subtype companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostaglandin E2 Receptor EP4 Subtyperevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of ONO-4232 Table 3. Key Players of KAG-308 Table 4. Key Players of ER-886046 Table 3. Key Players of Grapiprant Table 4. Key Players of E-7046 Table 5. Key Players of Others Table 6. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Breast Cancer Table 8. Key Players of Chronic Pain Table 9. Key Players of Acute Pain Table 10. Key Players of Allergies Table 11. Key Players of Lung Cancer Table 12. Key Players of Others Table 13. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Region (2021-2026) Table 16. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Region (2027-2032) Table 18. Prostaglandin E2 Receptor EP4 Subtype Industry Trends Table 19. Prostaglandin E2 Receptor EP4 Subtype Industry Drivers Table 20. Prostaglandin E2 Receptor EP4 Subtype Industry Opportunities and Challenges Table 21. Prostaglandin E2 Receptor EP4 Subtype Industry Restraints Table 22. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (US$ Million) & (2021-2026) Table 23. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Company (2021-2026) Table 24. Global Prostaglandin E2 Receptor EP4 Subtype Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 25. Global Prostaglandin E2 Receptor EP4 Subtype Key Company Head Office and Area Served Table 26. Global Prostaglandin E2 Receptor EP4 Subtype Company, Product Type & Application Table 27. Global Prostaglandin E2 Receptor EP4 Subtype Company Establishment Date Table 28. Global Company Market Concentration Ratio (CR5 and HHI) Table 29. Global Prostaglandin E2 Receptor EP4 Subtype by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 30. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026) & (US$ Million) Table 32. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032) & (US$ Million) Table 33. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2021-2026) Table 34. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2027-2032) Table 35. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026) & (US$ Million) Table 37. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032) & (US$ Million) Table 38. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2021-2026) Table 39. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2027-2032) Table 40. Eisai Co Ltd Company Information Table 41. Eisai Co Ltd Business Overview Table 42. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 44. Eisai Co Ltd Recent Development Table 45. Eli Lilly and Co Company Information Table 46. Eli Lilly and Co Business Overview Table 47. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 49. Eli Lilly and Co Recent Development Table 50. Rottapharm Biotech Srl Company Information Table 51. Rottapharm Biotech Srl Business Overview Table 52. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 54. Rottapharm Biotech Srl Recent Development Table 55. RaQualia Pharma Inc Company Information Table 56. RaQualia Pharma Inc Business Overview Table 57. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 59. RaQualia Pharma Inc Recent Development Table 60. Ono Pharmaceutical Co Ltd Company Information Table 61. Ono Pharmaceutical Co Ltd Business Overview Table 62. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 64. Ono Pharmaceutical Co Ltd Recent Development Table 65. Kaken Pharmaceutical Co Ltd Company Information Table 66. Kaken Pharmaceutical Co Ltd Business Overview Table 67. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio Table 69. Kaken Pharmaceutical Co Ltd Recent Development Table 70. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026) & (US$ Million) Table 71. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032) & (US$ Million) Table 72. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026) & (US$ Million) Table 73. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032) & (US$ Million) Table 74. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026) Table 76. North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2027-2032) Table 77. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026) & (US$ Million) Table 78. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032) & (US$ Million) Table 79. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026) & (US$ Million) Table 80. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032) & (US$ Million) Table 81. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026) Table 83. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2027-2032) Table 84. China Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026) & (US$ Million) Table 85. China Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032) & (US$ Million) Table 86. China Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026) & (US$ Million) Table 87. China Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026) & (US$ Million) Table 89. Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032) & (US$ Million) Table 90. Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026) & (US$ Million) Table 91. Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032) & (US$ Million) Table 92. Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026) Table 94. Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2027-2032) Table 95. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026) & (US$ Million) Table 98. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032) & (US$ Million) Table 99. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026) Table 101. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Prostaglandin E2 Receptor EP4 Subtype Product Image Figure 2. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Type: 2025 VS 2032 Figure 4. ONO-4232 Image Figure 5. KAG-308 Image Figure 6. ER-886046 Image Figure 7. Grapiprant Image Figure 8. E-7046 Image Figure 9. Others Image Figure 10. Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Application: 2025 VS 2032 Figure 12. Breast Cancer Image Figure 13. Chronic Pain Image Figure 14. Acute Pain Image Figure 15. Allergies Image Figure 16. Lung Cancer Image Figure 17. Others Image Figure 18. Global Prostaglandin E2 Receptor EP4 Subtype Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 20. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Region: 2025 VS 2032 Figure 21. Years Considered Figure 22. Global Prostaglandin E2 Receptor EP4 Subtype Market Share by Players in 2025 Figure 23. Global Top 5 and 10 Prostaglandin E2 Receptor EP4 Subtype Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Type (2021-2032) Figure 27. Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2021-2032) Figure 29. North America Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 30. North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032) Figure 31. North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032) Figure 32. North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2021-2032) Figure 33. United States Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 34. Canada Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 35. Mexico Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 36. Europe Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 37. Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032) Figure 38. Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032) Figure 39. Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2021-2032) Figure 40. Germany Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 41. France Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 42. U.K. Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 43. Italy Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 44. Russia Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 45. Nordic Countries Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 46. China Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 47. China Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032) Figure 48. China Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032) Figure 49. Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 50. Asia Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032) Figure 51. Asia Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032) Figure 52. Asia Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2021-2032) Figure 53. Japan Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 54. South Korea Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 55. Taiwan Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 56. Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 57. India Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 58. Australia Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 60. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032) Figure 61. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032) Figure 62. South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2021-2032) Figure 63. Brazil Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 64. South Africa Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 65. Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 66. Turkey Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 67. Argentina Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 68. UAE Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 69. Egypt Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 70. Chile Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032) & (US$ Million) Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • ONO-4232
  • KAG-308
  • ER-886046
  • Grapiprant
  • E-7046
  • Others
Applications
  • Breast Cancer
  • Chronic Pain
  • Acute Pain
  • Allergies
  • Lung Cancer
  • Others
Companies covered
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Rottapharm Biotech Srl
  • RaQualia Pharma Inc
  • Ono Pharmaceutical Co Ltd
  • Kaken Pharmaceutical Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 ONO-4232
  5. 1.2.3 KAG-308
  6. 1.2.4 ER-886046
  7. 1.2.5 Grapiprant
  8. 1.2.6 E-7046
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Breast Cancer
  13. 1.3.3 Chronic Pain
  14. 1.3.4 Acute Pain
  15. 1.3.5 Allergies
  16. 1.3.6 Lung Cancer
  17. 1.3.7 Others
  18. 1.4 Global Market Growth Prospects
  19. 1.5 Global Prostaglandin E2 Receptor EP4 Subtype Growth Trends by Region
  20. 1.5.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Region: 2021 VS 2025 VS 2032
  21. 1.5.2 Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2021-2026)
  22. 1.5.3 Prostaglandin E2 Receptor EP4 Subtype Market Size by Region (2027-2032)
  23. 1.6 Assumptions and Limitations
  24. 1.7 Study Goals and Objectives
  25. 1.8 Years Considered
2 Global Prostaglandin E2 Receptor EP4 Subtype Market Dynamics
  1. 2.1 Prostaglandin E2 Receptor EP4 Subtype Industry Trends
  2. 2.2 Prostaglandin E2 Receptor EP4 Subtype Industry Drivers
  3. 2.3 Prostaglandin E2 Receptor EP4 Subtype Industry Opportunities and Challenges
  4. 2.4 Prostaglandin E2 Receptor EP4 Subtype Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Company (2021-2026)
  2. 3.2 Global Prostaglandin E2 Receptor EP4 Subtype Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Prostaglandin E2 Receptor EP4 Subtype Key Company Head office and Area Served
  4. 3.4 Global Prostaglandin E2 Receptor EP4 Subtype Company, Product Type & Application
  5. 3.5 Global Prostaglandin E2 Receptor EP4 Subtype Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Prostaglandin E2 Receptor EP4 Subtype Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Prostaglandin E2 Receptor EP4 Subtype Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Prostaglandin E2 Receptor EP4 Subtype Tier 1, Tier 2, and Tier 3
4 Prostaglandin E2 Receptor EP4 Subtype Market by Type
  1. 4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2032)
  3. 4.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Share by Type (2021-2032)
5 Prostaglandin E2 Receptor EP4 Subtype Market by Application
  1. 5.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2032)
  3. 5.3 Global Prostaglandin E2 Receptor EP4 Subtype Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Eisai Co Ltd
  2. 6.1.1 Eisai Co Ltd Company Information
  3. 6.1.2 Eisai Co Ltd Business Overview
  4. 6.1.3 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  6. 6.1.5 Eisai Co Ltd Recent Developments
  7. 6.2 Eli Lilly and Co
  8. 6.2.1 Eli Lilly and Co Company Information
  9. 6.2.2 Eli Lilly and Co Business Overview
  10. 6.2.3 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  12. 6.2.5 Eli Lilly and Co Recent Developments
  13. 6.3 Rottapharm Biotech Srl
  14. 6.3.1 Rottapharm Biotech Srl Company Information
  15. 6.3.2 Rottapharm Biotech Srl Business Overview
  16. 6.3.3 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  18. 6.3.5 Rottapharm Biotech Srl Recent Developments
  19. 6.4 RaQualia Pharma Inc
  20. 6.4.1 RaQualia Pharma Inc Company Information
  21. 6.4.2 RaQualia Pharma Inc Business Overview
  22. 6.4.3 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  24. 6.4.5 RaQualia Pharma Inc Recent Developments
  25. 6.5 Ono Pharmaceutical Co Ltd
  26. 6.5.1 Ono Pharmaceutical Co Ltd Company Information
  27. 6.5.2 Ono Pharmaceutical Co Ltd Business Overview
  28. 6.5.3 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  30. 6.5.5 Ono Pharmaceutical Co Ltd Recent Developments
  31. 6.6 Kaken Pharmaceutical Co Ltd
  32. 6.6.1 Kaken Pharmaceutical Co Ltd Company Information
  33. 6.6.2 Kaken Pharmaceutical Co Ltd Business Overview
  34. 6.6.3 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product Portfolio
  36. 6.6.5 Kaken Pharmaceutical Co Ltd Recent Developments
7 North America
  1. 7.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032)
  2. 7.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
  3. 7.2.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026)
  4. 7.2.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032)
  5. 7.2.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032)
  6. 7.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
  7. 7.3.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026)
  8. 7.3.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032)
  9. 7.3.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032)
  10. 7.4 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country
  11. 7.4.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
  13. 7.4.3 North America Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2027-2032)
  14. 7.4.4 North America Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032)
  2. 8.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
  3. 8.2.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026)
  4. 8.2.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032)
  5. 8.2.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032)
  6. 8.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
  7. 8.3.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026)
  8. 8.3.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032)
  9. 8.3.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032)
  10. 8.4 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country
  11. 8.4.1 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
  13. 8.4.3 Europe Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2027-2032)
  14. 8.4.4 Europe Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032)
  2. 9.2 China Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
  3. 9.2.1 China Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026)
  4. 9.2.2 China Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032)
  5. 9.2.3 China Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032)
  6. 9.3 China Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
  7. 9.3.1 China Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026)
  8. 9.3.2 China Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032)
  9. 9.3.3 China Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032)
  2. 10.2 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
  3. 10.2.1 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026)
  4. 10.2.2 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032)
  5. 10.2.3 Asia Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032)
  6. 10.3 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
  7. 10.3.1 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026)
  8. 10.3.2 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032)
  9. 10.3.3 Asia Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032)
  10. 10.4 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Country
  11. 10.4.1 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
  13. 10.4.3 Asia Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2027-2032)
  14. 10.4.4 Asia Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst